Takeda Gets Serious About Regen Medicine With TiGenix Buy
Executive Summary
Takeda will acquire its Belgian biotech partner, TiGenix, to strengthen its gastro-intestinal portfolio, bolster its regenerative medicines capacity and grow its US specialty care presence.